Results 131 to 140 of about 80,483 (293)

Scleroderma [PDF]

open access: yesProceedings of the Royal Society of Medicine, 1956
M, FEIWEL, C D, CALNAN
openaire   +2 more sources

Effects of Audio‐Guided Imagery on Raynaud Phenomenon in Connective Tissue Disease

open access: yesACR Open Rheumatology, Volume 7, Issue 8, August 2025.
Objective To assess the physical, emotional, and mental impact of regular audio‐guided imagery (AGI) in patients with connective tissue disease (CTD)–associated Raynaud phenomenon (RP). Methods Sixteen adult patients with CTD‐associated RP were enrolled in an open‐label, single‐arm, eight‐week intervention with daily AGI at a single center.
Cristina Padilla   +7 more
wiley   +1 more source

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond

open access: yesAnnals of Neurology, Volume 98, Issue 2, Page 317-328, August 2025.
The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on ...
Joseph J. Sabatino Jr.   +2 more
wiley   +1 more source

Antifibrotic effects of specific targeting of the 5‐hydroxytryptamine 2B receptor (5‐HT2BR) in murine models and ex vivo models of scleroderma skin

open access: yesArthritis &Rheumatology, Volume 77, Issue 8, Page 1063-1076, August 2025.
Objective Systemic sclerosis (SSc) is a connective tissue disease with fibrotic remodeling of the skin and various internal organs. SSc is associated with the highest case‐specific mortality of all rheumatic autoimmune diseases with limited antifibrotic treatment options.
Thuong Trinh‐Minh   +12 more
wiley   +1 more source

Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

open access: yesNature Communications, 2023
Wenxia Wang   +23 more
doaj   +1 more source

Monoclonal Gammopathies of Clinical Significance—Scleromyxedema: A Case Report and Literature Review

open access: yesClinical Case Reports, Volume 13, Issue 8, August 2025.
ABSTRACT Scleromyxedema is an uncommon, chronic connective tissue disorder with an obscure etiology. It is distinguished by fibromyxoid skin lesions and elevated serum monoclonal immunoglobulin levels. The condition's rarity limits epidemiological data, making prevalence and incidence assessment difficult.
Shanshan Liang   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy